Human immunodeficiency virus-1 protein Tat induces excitotoxic loss of presynaptic terminals in hippocampal cultures

Molecular and Cellular Neuroscience

Volumn 54, Issue , 2013, Pages 22-29

  Shin, Angela H ^a   Thayer, Stanley A ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Excitotoxicity; HIV 1 Tat; HIV associated neurocognitive disorders; Presynaptic terminal; Synapse loss

Indexed keywords

IFENPRODIL; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; NUTLIN 3; SYNAPTOPHYSIN; TRANSACTIVATOR PROTEIN;

ANIMAL TISSUE; ARTICLE; EXCITOTOXICITY; HIPPOCAMPUS; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOREACTIVITY; NERVE ENDING; NONHUMAN; POSTSYNAPTIC MEMBRANE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN LOCALIZATION; RAT; TREATMENT DURATION;

ANIMALS; CELLS, CULTURED; HIPPOCAMPUS; HIV-1; IMIDAZOLES; LDL-RECEPTOR RELATED PROTEINS; NEURONS; PIPERAZINES; PIPERIDINES; PRESYNAPTIC TERMINALS; RATS; RECEPTORS, N-METHYL-D-ASPARTATE; SYNAPTOPHYSIN; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84872779742     PISSN: 10447431     EISSN: 10959327     Source Type: Journal    
DOI: 10.1016/j.mcn.2012.12.005     Document Type: Article

References (56)

1. Aksenova M.V., Aksenov M.Y., Adams S.M., Mactutus C.F., Booze R.M. Neuronal survival and resistance to HIV-1 Tat toxicity in the primary culture of rat fetal neurons. Exp. Neurol. 2008, 215:253-263.
2. Bianchetta M.J., Lam T.T., Jones S.N., Morabito M.A. Cyclin-dependent kinase 5 regulates PSD-95 ubiquitination in neurons. J. Neurosci. 2011, 31:12029-12035.
3. Chavis P., Westbrook G. Integrins mediate functional pre- and postsynaptic maturation at a hippocampal synapse. Nature 2001, 411:317-321.
4. Christopherson K.S., Hillier B.J., Lim W.A., Bredt D.S. PSD-95 assembles a ternary complex with the N-methyl-d-aspartic acid receptor and a bivalent neuronal NO synthase PDZ domain. J. Biol. Chem. 1999, 274:27467-27473.
5. Colledge M., Snyder E.M., Crozier R.A., Soderling J.A., Jin Y., Langeberg L.K., Lu H., Bear M.F., Scott J.D. Ubiquitination regulates PSD-95 degradation and AMPA receptor surface expression. Neuron 2003, 40:595-607.
6. Cysique L.A., Maruff P., Brew B.J. Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two cohorts. J. Neurovirol. 2004, 10:350-357.
7. Del Valle L., Croul S., Morgello S., Amini S., Rappaport J., Khalili K. Detection of HIV-1 Tat and JCV capsid protein, VP1, in AIDS brain with progressive multifocal leukoencephalopathy. J. Neurovirol. 2000, 6:221-228.
8. Ellis R., Langford D., Masliah E. HIV and antiretroviral therapy in the brain: neuronal injury and repair. Nat. Rev. Neurosci. 2007, 8:33-44.
9. Eugenin E.A., King J.E., Nath A., Calderon T.M., Zukin R.S., Bennett M.V., Berman J.W. HIV-tat induces formation of an LRP-PSD-95-NMDAR-nNOS complex that promotes apoptosis in neurons and astrocytes. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:3438-3443.
10. Everall I.P., Heaton R.K., Marcotte T.D., Ellis R.J., McCutchan J.A., Atkinson J.H., Grant I., Mallory M., Masliah E. Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. HNRC Group. HIV Neurobehavioral Research Center. Brain Pathol. 1999, 9:209-217.
11. Fitting S., Xu R., Bull C., Buch S., El-Hage N., Nath A., Knapp P.E., Hauser K.F. Interactive comorbidity between opioid drug abuse and HIV-1 Tat: chronic exposure augments spine loss and sublethal dendritic pathology in striatal neurons. Am. J. Pathol. 2010, 177:1397-1410.
12. Fletcher T.L., Cameron P., De Camilli P., Banker G. The distribution of synapsin I and synaptophysin in hippocampal neurons developing in culture. J. Neurosci. 1991, 11:1617-1626.
13. Friedman H.V., Bresler T., Garner C.C., Ziv N.E. Assembly of new individual excitatory synapses: time course and temporal order of synaptic molecule recruitment. Neuron 2000, 27:57-69.
14. Fykse E.M., Takei K., Walch-Solimena C., Geppert M., Jahn R., De Camilli P., Sudhof T.C. Relative properties and localizations of synaptic vesicle protein isoforms: the case of the synaptophysins. J. Neurosci. 1993, 11:4997-5007.
15. Genis P., Jett M., Bernton E.W., Boyle T., Gelbard H.A., Dzenko K., Keane R.W., Resnick L., Mizrachi Y., Volsky D.J., Epstein L.G., Gendelman H.E. Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage interactions: implications for the neuropathogenesis of HIV disease. J. Exp. Med. 1992, 176:1703-1718.
16. Gray J.A., Shi Y., Usui H., During M.J., Sakimura K., Nicoll R.A. Distinct modes of AMPA receptor suppression at developing synapses by GluN2A and GluN2B: single-cell NMDA receptor subunit deletion in vivo. Neuron 2011, 71:1085-1101.
17. Hofman F.M., Dohadwala M.M., Wright A.D., Hinton D.R., Walker S.M. Exogenous tat protein activates central nervous system-derived endothelial cells. J. Neuroimmunol. 1994, 54:19-28.
18. Hudson L., Liu J., Nath A., Jones M., Raghavan R., Narayan O., Male D., Everall I. Detection of the human immunodeficiency virus regulatory protein Tat in CNS tissues. J. Neurovirol. 2000, 6:145-155.
19. Hult B., Chana G., Masliah E., Everall I. Neurobiology of HIV. Int. Rev. Psychiatry 2008, 20:3-13.
20. Johnston P.A., Sudhof T.C. The multisubunit structure of synaptophysin. J. Biol. Chem. 1990, 265:8869-8873.
21. Kaul M., Lipton S.A. Mechanisms of neuronal injury and death in HIV-1 associated dementia. Curr. HIV Res. 2006, 4:307-318.
22. Kaul M., Garden G.A., Lipton S.A. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 2001, 410:988-994.
23. Kim H.J., Thayer S.A. Lithium increases synapse formation between hippocampal neurons by depleting phosphoinositides. Mol. Pharmacol. 2009, 75:1021-1030.
24. Kim B.O., Liu Y., Ruan Y., Xu Z.C., Schantz L., He J.J. Neuropathologies in transgenic mice expressing human immunodeficiency virus type 1 Tat protein under the regulation of the astrocyte-specific glial fibrillary acidic protein promoter and doxycycline. Am. J. Pathol. 2003, 162:1693-1707.
25. Kim H.J., Martemyanov K.A., Thayer S.A. Human immunodeficiency virus protein Tat induces synapse loss via a reversible process that is distinct from cell death. J. Neurosci. 2008, 28:12604-12613.
26. Kim H.J., Shin A.H., Thayer S.A. Activation of cannabinoid type 2 receptors inhibits HIV-1 envelope glycoprotein gp120-induced synapse loss. Mol. Pharmacol. 2011, 80:357-366.
27. Li W., Huang Y., Reid R., Steiner J., Malpica-Llanos T., Darden T.A., Shankar S.K., Mahadevan A., Satishchandra P., Nath A. NMDA receptor activation by HIV-Tat protein is clade dependent. J. Neurosci. 2008, 28:12190-12198.
28. Li W., Li G., Steiner J., Nath A. Role of Tat protein in HIV neuropathogenesis. Neurotox. Res. 2009, 16:205-220.
29. Liu Y., Jones M., Hingtgen C.M., Bu G., Laribee N., Tanzi R.E., Moir R.D., Nath A., He J.J. Uptake of HIV-1 tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands. Nat. Med. 2000, 6:1380-1387.
30. Liu L., Wong T.P., Pozza M.F., Lingenhoehl K., Wang Y., Sheng M., Auberson Y.P., Wang Y.T. Role of NMDA receptor subtypes in governing the direction of hippocampal synaptic plasticity. Science 2004, 304:1021-1024.
31. Liu Y., Wong T.P., Aarts M., Rooyakkers A., Liu L., Lai T.W., Wu D.C., Lu J., Tymianski M., Craig A.M., Wang Y.T. NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo. J. Neurosci. 2007, 27:2846-2857.
32. Masliah E., Heaton R.K., Marcotte T.D., Ellis R.J., Wiley C.A., Mallory M., Achim C.L., McCutchan J.A., Nelson J.A., Atkinson J.H., Grant I. Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center. Ann. Neurol. 1997, 42:963-972.
33. McMahon H.T., Bolshakov V.Y., Janz R., Hammer R.E., Siegelbaum S.A., Sudof T.C. Synaptophysin, a major synaptic vesicle protein, is not essential for neurotransmitter release. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:4760-4764.
34. Meyer G., Varoqueaux F., Neeb A., Oschlies M., Brose N. The complexity of PDZ domain-mediated interactions at glutamatergic synapses: a case study on neuroligin. Neuropharmacology 2004, 47:724-733.
35. Midde N., Gomez A., Zhu J. HIV-1 Tat protein decreases dopamine transporter cell surface expression and vesicular monoamine transporter-2 function in rat striatal synaptosomes. J. Neuroimmune Pharmacol. 2012, 7:629-639.
36. Minagar A., Commins D., Alexander J.S., Hoque R., Chiappelli F., Singer E.J., Nikbin B., Shapshak P. NeuroAIDS: characteristics and diagnosis of the neurological complications of AIDS. Mol. Diagn. Ther. 2008, 12:25-43.
37. Mishra A., Kim H.J., Shin A.H., Thayer S.A. Synapse loss induced by interleukin-1β requires pre- and post-synaptic mechanisms. J. Neuroimmune Pharmacol. 2012, 7:571-578.
38. Perry S., Barbieri J., Tong N., Polesskaya O., Pudasaini S., Stout A., Lu R., Kiebala M., Maggirwar S., Gelbard H. Human immunodeficiency virus-1 Tat activates calpain proteases via the ryanodine receptor to enhance surface dopamine transporter levels and increase transporter-specific uptake and Vmax. J. Neurosci. 2010, 30:14153-14164.
39. Rehm H., Wiedenmann B., Betz H. Molecular characterization of synaptophysin, a major calcium-binding protein of the synaptic vesicle membrane. EMBO J. 1986, 5:535-541.
40. Sa M.J., Madeira M.D., Ruela C., Volk B., Mota-Miranda A., Paula-Barbosa M.M. Dendritic changes in the hippocampal formation of AIDS patients: a quantitative Golgi study. Acta Neuropathol. (Berl) 2004, 107:97-110.
41. Scheiffele P., Fan J., Choih J., Fetter R., Serafini T. Neuroligin expressed in nonneuronal cells triggers presynaptic development in contacting axons. Cell 2000, 101:657-669.
42. Shen M., Thayer S.A. The cannabinoid agonist Win, 55,212-2 inhibits calcium channels by receptor-mediated and direct pathways in cultured rat hippocampal neurons. Brain Res. 1998, 783:77-84.
43. Shin A.H., Kim H.J., Thayer S.A. Subtype selective NMDA receptor antagonists induce recovery of synapses lost following exposure to HIV-1 Tat. Br. J. Pharmacol. 2012, 166:1002-1017.
44. Speth C., Stockl G., Mohsenipour I., Wurzner R., Stoiber H., Lass-Florl C., Dierich M.P. Human immunodeficiency virus type 1 induces expression of complement factors in human astrocytes. J. Virol. 2001, 75:2604-2615.
45. Theodore S., Cass W., Dwoskin L., Maragos W. HIV-1 protein Tat inhibits vesicular monoamine transporter-2 activity in rat striatum. Synapse 2012, 66:755-757.
46. Togashi H., Abe K., Mizoguchi A., Takaoka K., Chisaka O., Masatoshi T. Cadherin regulates dendritic spine morphogenesis. Neuron 2002, 35:77-89.
47. tom Dieck S., Sanmarti-Vila L., Langnaese K., Richter K., Kindler S., Soyke A., Wex H., Smalla K.H., Kampf U., Franzer J.-T., Stumm M., Garner C.C., Gundelfinger E.D. Bassoon, a novel zinc-finger CAG/glutamine-repeat protein selectively localized at the active zone of presynaptic nerve terminals. J. Cell Biol. 1998, 142:499-509.
48. Tozzi V., Balestra P., Lorenzini P., Bellagamba R., Galgani S., Corpolongo A., Vlassi C., Larussa D., Zaccarelli M., Noto P., Visco-Comandini U., Giulianelli M., Ippolito G., Antinori A., Narciso P. Prevalence and risk factors for human immunodeficiency virus-associated neurocognitive impairment, 1996 to 2002: results from an urban observational cohort. J. Neurovirol. 2005, 11:265-273.
49. Waataja J.J., Kim H.J., Roloff A.M., Thayer S.A. Excitotoxic loss of post-synaptic sites is distinct temporally and mechanistically from neuronal death. J. Neurochem. 2008, 104:364-375.
50. Westendorp M.O., Frank R., Ochsenbauer C., Stricker K., Dhein J., Walczak H., Debatin K.M., Krammer P.H. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 1995, 375:497-500.
51. Wiedenmann B., Franke W. Identification and localization of synaptophysin, an integral membrane glycoprotein of Mr 38,000 characteristic of presynaptic vesicles. Cell 1985, 41:1017-1028.
52. Wiley C.A., Baldwin M., Achim C.L. Expression of regulatory and structural mRNA in the central nervous system. AIDS 1996, 10:943-947.
53. Wiley C.A., Masliah E., Achim C.L. Measurement of CNS HIV burden and its association with neurologic damage. Adv. Neuroimmunol. 1999, 4:319-325.
54. Xiao H., Neuveut C., Lee H., Benkirane M., Rich E.A., Murphy P.M., Jeang K.-T. Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:11466-11471.
55. Ziv N.E. Recruitment of synaptic molecules during synaptogenesis. Neuroscientist 2001, 7:365-370.
56. Ziv N.E., Garner C.C. Cellular and molecular mechanisms of presynaptic assembly. Nat. Rev. Neurosci. 2004, 5:385-399.